ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 224 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q4 2022. The put-call ratio across all filers is 0.80 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $418,000 | -24.0% | 10,086 | +33.1% | 0.10% | -35.8% |
| Q1 2022 | $550,000 | +67.7% | 7,580 | +94.4% | 0.15% | +32.1% |
| Q4 2021 | $328,000 | +11.9% | 3,900 | +20.0% | 0.11% | +17.9% |
| Q3 2021 | $293,000 | +20.6% | 3,250 | +27.5% | 0.10% | -5.0% |
| Q2 2021 | $243,000 | -40.7% | 2,550 | -29.2% | 0.10% | -60.3% |
| Q1 2021 | $410,000 | -27.7% | 3,600 | -72.8% | 0.25% | +17.8% |
| Q3 2019 | $567,000 | +34.0% | 13,244 | +50.7% | 0.21% | -48.7% |
| Q4 2018 | $423,000 | – | 8,790 | – | 0.42% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| First Light Asset Management, LLC | 437,512 | $31,772,000 | 2.80% |
| RTW INVESTMENTS, LP | 1,373,284 | $99,728,000 | 2.06% |
| Rock Springs Capital Management LP | 1,028,109 | $74,661,000 | 1.88% |
| Privium Fund Management B.V. | 112,727 | $8,186,000 | 1.81% |
| Avidity Partners Management LP | 869,000 | $63,107,000 | 1.31% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 525,100 | $38,133,000 | 1.16% |
| Boxer Capital, LLC | 200,000 | $14,524,000 | 0.75% |
| SECTOR GAMMA AS | 46,221 | $3,357,000 | 0.73% |
| FEDERATED HERMES, INC. | 3,987,728 | $289,589,000 | 0.65% |
| EMERALD ADVISERS, LLC | 223,952 | $16,263,000 | 0.62% |